Our global leadership in schizophrenia is well known throughout industry and academia. We support numerous clinical and neurocognitive endpoints, including assessment of at-risk status, conversion to psychosis, and functional capacity. We also support clinical development programs in bipolar disorder, major depressive disorder, post-traumatic stress disorder, attention-deficit disorder, and other conditions affecting mental health and cognition.
Areas of expertise include
- ADHD
- ALS
- Alzheimer's
- Bipolar disorder
- Dementia
- MS
- Migraine
- Post-traumatic stress
- Schizophrenia